Christian Frauendorf

This inventor holds 12 USPTO granted patents and 10 published patent applications, plus 4 CIPO patents and 6 EPO patents. Top assignee: Silence Therapeutics Gmbh. Active years: 2021-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Christian Frauendorf. Retrieved from https://idiyas.com/inventor/christian-frauendorf

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 12 (Patent Applications = 10)

% Patents Active = 100.0

CIPO Patents = 4 (Patent Applications = 5)

EPO Patents = 6 (Patent Applications = 24)

Average Co-Inventor Count = 3.6

ph-index = 2

Forward Citations = 35(Granted Patents)

Company Filing History:

12 out of 38

Silence Therapeutics Gmbh

patents

Years Active: 2021-2024

Loading Chart...

12 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12084656 - Products and compositions (2024-09-10),

2. 12054717 - Nucleic acids for inhibiting expression of LPA in a cell (2024-08-06),

3. 11987794 - Products and compositions (2024-05-21),

4. 11912993 - Nucleic acid linked to a trivalent glycoconjugate (2024-02-27),

5. 11873489 - Nucleic acids for inhibiting expression of a target gene comprising phosphorodithioate linkages (2024-01-16),

6. 11499153 - Nucleic acids for inhibiting expression of LPA in a cell (2022-11-15),

7. 11414660 - Products and compositions (2022-08-16),

8. 11319537 - Nucleic acids for inhibiting expression of LPA in a cell (2022-05-03),

9. 11299738 - Further novel oligonucleotide-ligand conjugates (2022-04-12),

10. 11174483 - Products and compositions (2021-11-16),

11. 11015198 - Products and compositions (2021-05-25),

12. 10913945 - Nucleic acid linked to a trivalent glycoconjugate (2021-02-09),

Title: The Innovative Mind of Christian Frauendorf

Introduction

Christian Frauendorf, based in Berlin, Germany, is a distinguished inventor known for his significant contributions to the field of biotechnology. With an impressive portfolio of 12 patents, Frauendorf's work focuses on groundbreaking therapeutic applications that target gene expression, providing hope for various diseases and disorders.

Latest Patents

Frauendorf's latest inventions include innovative products and compositions designed to interfere with gene expression. One notable patent addresses nucleic acid products that inhibit gene expression for therapeutic uses, aimed at treating numerous diseases. Another significant patent centers on nucleic acids specifically targeting the LPA gene, which has implications for the treatment, prevention, and reduction of risks associated with cardiovascular diseases such as coronary heart disease, aortic stenosis, and strokes. These inventions highlight his commitment to advancing medical science through innovative genetic therapies.

Career Highlights

Currently, Frauendorf is a key contributor at Silence Therapeutics GmbH, where he actively engages in research and development efforts to enhance therapeutic outcomes. His dedication to innovation in biotechnology is evident in his expansive array of patents that continue to push the boundaries of current medical treatments.

Collaborations

In his journey, Frauendorf has collaborated with talented individuals such as Judith Hauptmann and Lucas Bethge, further enriching his work environment with diverse ideas and expertise. These collaborations have fostered a creative atmosphere that encourages advancements in therapeutic technologies.

Conclusion

Christian Frauendorf exemplifies the spirit of innovation within the biotechnology field. His relentless pursuit of new solutions to complex health issues through his patents represents a significant step forward in the treatment of various disorders. As he continues to develop groundbreaking therapies, the medical community eagerly anticipates the impact of his work on improving patient outcomes worldwide.

Profile summary based on public USPTO records.